Mirum Pharmaceuticals, Inc. (MIRM) Earnings Call Transcripts

42 earnings calls from December 2020 to September 28, 2026

NasdaqGM US Health Care Biotechnology

About Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. (MIRM) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqGM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 42 calls on record spanning December 9, 2020 to September 28, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 42 Mirum Pharmaceuticals, Inc. earnings call transcripts on record, spanning December 9, 2020 to September 28, 2026. Based on this history, Mirum Pharmaceuticals, Inc. reports quarterly. The most recent call on file is dated September 28, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
MIRM
Exchange
NasdaqGM
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
42
First call
December 9, 2020
Most recent
September 28, 2026
Reporting cadence
quarterly
Quarter Date
Special Calls Sep 28, 2026 Read transcript →
Company Conference Presentations Sep 16, 2026 Read transcript →
Company Conference Presentations Sep 10, 2026 Read transcript →
Q2 FY2026 Aug 5, 2026 Read transcript →
Q1 FY2026 May 6, 2026 Read transcript →
Special Calls May 4, 2026 Read transcript →
Q4 FY2025 Feb 25, 2026 Read transcript →
Company Conference Presentations Jan 14, 2026 Read transcript →
Company Conference Presentations Dec 2, 2025 Read transcript →
Q3 FY2025 Nov 4, 2025 Read transcript →
Company Conference Presentations Sep 8, 2025 Read transcript →
Q2 FY2025 Aug 6, 2025 Read transcript →
Q1 FY2025 May 7, 2025 Read transcript →
Q4 FY2024 Feb 26, 2025 Read transcript →
Company Conference Presentations Jan 15, 2025 Read transcript →
Q3 FY2024 Nov 12, 2024 Read transcript →
Company Conference Presentations Sep 4, 2024 Read transcript →
Q2 FY2024 Aug 7, 2024 Read transcript →
Special Calls Jun 17, 2024 Read transcript →
Company Conference Presentations Jun 12, 2024 Read transcript →
Q1 FY2024 May 8, 2024 Read transcript →
Q4 FY2023 Feb 28, 2024 Read transcript →
Company Conference Presentations Jan 10, 2024 Read transcript →
Company Conference Presentations Nov 8, 2023 Read transcript →
Q3 FY2023 Nov 2, 2023 Read transcript →
Company Conference Presentations Sep 13, 2023 Read transcript →
Q2 FY2023 Aug 3, 2023 Read transcript →
Q1 FY2023 May 4, 2023 Read transcript →
Q4 FY2022 Mar 8, 2023 Read transcript →
Company Conference Presentations Jan 10, 2023 Read transcript →
Q3 FY2022 Nov 9, 2022 Read transcript →
Special Calls Oct 24, 2022 Read transcript →
Q2 FY2022 Aug 4, 2022 Read transcript →
Q1 FY2022 May 5, 2022 Read transcript →
Q4 FY2021 Mar 9, 2022 Read transcript →
Company Conference Presentations Jan 11, 2022 Read transcript →
Q3 FY2021 Nov 15, 2021 Read transcript →
Special Calls Sep 29, 2021 Read transcript →
Q2 FY2021 Aug 5, 2021 Read transcript →
Q1 FY2021 May 6, 2021 Read transcript →
Company Conference Presentations Jan 12, 2021 Read transcript →
Analyst/Investor Day Dec 9, 2020 Read transcript →